Pathways of Neuronal Damage Involving Macrophage-Glia Interactions In Vivo

体内涉及巨噬细胞-神经胶质相互作用的神经元损伤途径

基本信息

项目摘要

We propose that astrocyte dysfunction in HIV-1-associated dementia (HAD) occurs through its Interactions with infected brain mononuclear phagocytes (MP; perivascular and parenchymal macrophages and microglia). We will study how this occurs taking advantage of a newly developed proteomics and imaging facllity within our center. Magnetic resonance imaging (1HMRI), 1HMRS spectroscopy and single proton emission computed tomography will access cell movement and functlon in a rodent animal model of human HAD and HIV encephalitis (HIVE). The work will investigate how MP Infection and/or activation affects astrocyte neuroregulatory functions as well as explore primary infection of astrocytes de novo. It is proposed that secretion of MP pro-inflammatory factors (for example, tumor necrosis factor, quinolinlc acid and platelet activating factor) attenuates astrocyte signaling pathways leading to the down regulation of glial trophins including brain derived neurotrophic factor, glial derived neurotrophic factor, nerve growth factor, and/or transforming growth factor beta as well as attenuating glutamate transporter function, HIV-infected macrophages secretions (cellular or viral products) may also inclte the production of neurotoxins from astrocytes (for example, nitric oxide), glutamate, interleukin-1beta, MP-astrocyte interactions will be investigated for their abilities to affect autocrine and/or paracrine amplification of glial neurotoxins and chemotactic function. The relative role of virus and astrocyte secretory responses will be studied for its influence in the neuropathogenesis of HIV infection in a severe combined immunodeficient (SCID) mouse model of human disease. SCID mice will be injected intracerebrally with productively infected human astrocytes with vesicular stomatitis virus expressing HIV-1, with lymphotropic (LAI) or macrophage tropic (DVJ, ADA or JR-FL) viruses. The generation of cytotoxlc T lymphocytes from reconstituted HIVE mice will be used to eliminate infected macrophages from the brain and permit the assessment and evaluation of astrocyte repair processes. Lastly, a novel, state-of-art proteomics facility that includes on-line protein sequencing, will establish a comprehensive database of global changes of protein expression in human primary astrocytes as it relates to cell functlon. Altogether, these works will permit the determination of astrocyte and neuronal functions evaluated as a consequence of HIV-1 infection, MP function and chemotaxis in laboratory and animal models of human HAD. Most importantly, the project has strong collaborative ties with each of the other projects focusing on a unique but as yet understudied part of NeuroAIDS, namely the role played by astrocytes in the disease process.
我们提出,在HIV-1相关性痴呆(HAD)中,星形胶质细胞功能障碍通过其与受感染的脑单核吞噬细胞(MP;血管周围和实质巨噬细胞和小胶质细胞)的相互作用而发生。我们将研究这是如何发生的,利用我们中心新开发的蛋白质组学和成像设施。磁共振成像(1HMRI),1HMRS光谱和单质子发射计算机断层扫描将访问人类HAD和HIV脑炎(HIVE)的啮齿动物模型中的细胞运动和功能。这项工作将研究MP感染和/或激活如何影响星形胶质细胞的神经调节功能,以及探索星形胶质细胞的原发性感染。提示MP促炎因子的分泌(例如,肿瘤坏死因子、喹啉酸和血小板活化因子)减弱星形胶质细胞信号传导途径,导致神经胶质营养因子(包括脑源性神经营养因子、神经胶质源性神经营养因子、神经生长因子和/或转化生长因子β)的下调,以及减弱谷氨酸转运蛋白功能,HIV感染的巨噬细胞分泌物(细胞或病毒产物)也可能包括星形胶质细胞产生神经毒素(例如,一氧化氮)、谷氨酸、白细胞介素-1 β、MP-星形胶质细胞相互作用,将研究其影响神经胶质细胞神经毒素自分泌和/或旁分泌扩增和趋化功能的能力。将研究病毒和星形胶质细胞分泌反应的相对作用,以了解其对细胞增殖的影响。 在人类疾病的严重联合免疫缺陷(SCID)小鼠模型中HIV感染的神经发病机制。用表达HIV-1的水泡性口炎病毒、嗜淋巴细胞(LAI)或嗜巨噬细胞(DVJ、ADA或JR-FL)病毒对SCID小鼠进行脑内注射生产性感染的人星形胶质细胞。从重组HIVE小鼠中产生细胞毒性T淋巴细胞将用于从脑中清除感染的巨噬细胞,并允许评估和评价星形胶质细胞修复过程。最后,一个新的,最先进的蛋白质组学设施,包括在线蛋白质测序,将建立一个全面的数据库的全球变化的蛋白质表达在人类初级星形胶质细胞,因为它涉及到细胞functionlon。总之,这些工作将允许确定星形胶质细胞和神经元 作为HIV-1感染的结果,在实验室和人类HAD动物模型中评价MP功能和趋化性。最重要的是,该项目与其他每个项目都有很强的合作关系,这些项目专注于NeuroAIDS的一个独特但尚未充分研究的部分,即星形胶质细胞在疾病过程中发挥的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Howard E Gendelman其他文献

HIV-1 hijacks tunneling nanotubes and secretory microvesicles for intercellular spread in monocyte-derived macrophages
  • DOI:
    10.1186/1742-4690-6-s2-o22
  • 发表时间:
    2009-09-24
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Irena Kadiu;Jan M Orenstein;Howard E Gendelman
  • 通讯作者:
    Howard E Gendelman

Howard E Gendelman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Howard E Gendelman', 18)}}的其他基金

HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes
CNS 单核吞噬细胞中 HIV-1 的检测和消除
  • 批准号:
    10645139
  • 财政年份:
    2021
  • 资助金额:
    $ 21.49万
  • 项目类别:
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes
CNS 单核吞噬细胞中 HIV-1 的检测和消除
  • 批准号:
    10454408
  • 财政年份:
    2021
  • 资助金额:
    $ 21.49万
  • 项目类别:
HIV-1 Detection and Elimination From CNS Mononuclear Phagocytes
CNS 单核吞噬细胞中 HIV-1 的检测和消除
  • 批准号:
    10327550
  • 财政年份:
    2021
  • 资助金额:
    $ 21.49万
  • 项目类别:
Neuroimmunology of Disease Training Program
疾病神经免疫学培训计划
  • 批准号:
    10200159
  • 财政年份:
    2018
  • 资助金额:
    $ 21.49万
  • 项目类别:
Neuroimmunology of Disease Training Program
疾病神经免疫学培训计划
  • 批准号:
    10629027
  • 财政年份:
    2018
  • 资助金额:
    $ 21.49万
  • 项目类别:
Neuroimmunology of Disease Training Program
疾病神经免疫学培训计划
  • 批准号:
    10875267
  • 财政年份:
    2018
  • 资助金额:
    $ 21.49万
  • 项目类别:
Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1
用于消除 HIV-1 的联合分子切除疗法 (CMET)
  • 批准号:
    10217975
  • 财政年份:
    2017
  • 资助金额:
    $ 21.49万
  • 项目类别:
Glutaminase and its neurotoxic link to HAND
谷氨酰胺酶及其与 HAND 的神经毒性联系
  • 批准号:
    9700732
  • 财政年份:
    2016
  • 资助金额:
    $ 21.49万
  • 项目类别:
SMART HAND
智能手
  • 批准号:
    8738559
  • 财政年份:
    2013
  • 资助金额:
    $ 21.49万
  • 项目类别:
SMART HAND
智能手
  • 批准号:
    8875562
  • 财政年份:
    2013
  • 资助金额:
    $ 21.49万
  • 项目类别:

相似海外基金

A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
  • 批准号:
    MR/V035304/1
  • 财政年份:
    2022
  • 资助金额:
    $ 21.49万
  • 项目类别:
    Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
  • 批准号:
    10369859
  • 财政年份:
    2021
  • 资助金额:
    $ 21.49万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10461964
  • 财政年份:
    2021
  • 资助金额:
    $ 21.49万
  • 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
  • 批准号:
    10326617
  • 财政年份:
    2021
  • 资助金额:
    $ 21.49万
  • 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
  • 批准号:
    404211
  • 财政年份:
    2018
  • 资助金额:
    $ 21.49万
  • 项目类别:
    Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
  • 批准号:
    9078083
  • 财政年份:
    2015
  • 资助金额:
    $ 21.49万
  • 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
  • 批准号:
    9079323
  • 财政年份:
    2015
  • 资助金额:
    $ 21.49万
  • 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
  • 批准号:
    9079336
  • 财政年份:
    2015
  • 资助金额:
    $ 21.49万
  • 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
  • 批准号:
    8472130
  • 财政年份:
    2012
  • 资助金额:
    $ 21.49万
  • 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
  • 批准号:
    8532661
  • 财政年份:
    2011
  • 资助金额:
    $ 21.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了